Following are recent articles providing perspective from Kendle subject matter experts on various clinical development topics, therapeutic areas or current industry trends. New material is added frequently, so check back again soon to view the latest updates.
 |
One step ahead
PharmaTimes Journal, Nov 2007 |
|
Moving Toward a Future of Biomarker-Driven Personalized Medicine
Regulatory Affairs Focus, Oct 2007 |
|
Best practices
in patient access
and retention
PharmaTimes Journal, Sept 2007 |
|
CROs come of age in partnering with pharma
GCPj sponsored supplement, June 2007 |
|
E-endpoint reporting justifies the means
Good Clinical Practice Journal, June 2007
Drew Kilpatrick, Director of Global Safety and Pharmacovigilance, - Glasgow, Scotland; Liza Mumford, Senior Safety Specialist - Glasgow, Scotland; Lynn Dunlop, Senior Safety Specialist - Glasgow, Scotland |
|
U.S. Sites Rate Kendle, Covance, Omnicare as Top CROs in 2007
The CenterWatch Monthly, June 2007 |
|
Realising global patient recruitment
GCPj sponsored supplement, May 2007 |
|
EDC Guru Moves from Novartis to Kendle
BioIT World, April 2007 |
|
Trials in melanoma: Feeling the burn?
Good Clinical Practice Journal, April 2007
John Whittaker, PhD, Director, Global Clinical Development - Europe, Oncology; Ewan Miller, MD, Medical Director, Global Clinical Development - Europe; Navinder Blundell, BSc, Project Leader, Global Clinical Development - Europe |
|
Everybody wins
ITC, March 2007
Dr Janet Jones, Sr. Director, Global Strategic Patient Access |
|
Real people, real rewards
Scrip World Pharmaceutical News March 2007 |
|
Regulatory Challenges of Global Pivotal Clinical Trials
Regulatory Affairs Focus, March 2007
Melanie Bruno, MBA, PhD, Vice President, Regulatory Affairs and Quality
William Sietsema, PhD, Vice President, Clinical and Regulatory Strategic Planning |
|
20 Notable People in R&D
R&D Directions, February 2007 |
|
Where next for targeted cancer treatments?
Good Clinical Practice Journal, January 2007
John Whittaker, PhD, Director, Global Clinical Development - Europe, Oncology |
|
Pharma's Eastern Promise
Pharmafocus, January 2007
Christopher Bergen, President and Chief Operating Officer |
Files require Adobe Acrobat Reader 
|
